As of December 31, 2024, Purple Biotech (PPBT) had cash and cash equivalents and short-term deposits of $8.2 million, providing the Company a cash runway into mid-2026.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PPBT: